Profile
Mr. Lukas Linnig is a Co-Chief Executive Officer at Akribion Therapeutics.
Mr. Linnig was previously employed as a Chief Financial Officer by BRAIN Biotech AG and a Project Manager by Venture Stars GmbH.
He also served on the board at B.R.A.I.N.
Biotechnology Research & Info Network UK Ltd. He received his undergraduate degree from the University of Hagen.
Lukas Linnig active positions
| Companies | Position | Start |
|---|
Former positions of Lukas Linnig
| Companies | Position | End |
|---|---|---|
B.R.A.I.N. Biotechnology Research & Info Network UK Ltd.
B.R.A.I.N. Biotechnology Research & Info Network UK Ltd. BiotechnologyHealth Technology Supplies bio-based products and solutions | Director/Board Member | 09/02/2023 |
| BRAIN BIOTECH AG | Director of Finance/CFO | 01/10/2022 |
Venture Stars GmbH
Venture Stars GmbH Investment ManagersFinance Ventures Stars develops and invests in start-up businesses. The firm specializes in developing and financing the growth of businesses, operating in the legal, finance, investor relations, marketing, human resources, and information technology sectors. Its focus areas encompass portfolio management, project management, brand development, and business financing. The firm typically investing €500k - 2m EUR initially and up to 4m in total per company. | Corporate Officer/Principal | - |
Training of Lukas Linnig
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Hagen
University of Hagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BRAIN Biotech AG
BRAIN Biotech AG BiotechnologyHealth Technology Discovers and develops bioactive natural compounds and proprietary enzymes | Health Technology |
Venture Stars GmbH
Venture Stars GmbH Investment ManagersFinance Ventures Stars develops and invests in start-up businesses. The firm specializes in developing and financing the growth of businesses, operating in the legal, finance, investor relations, marketing, human resources, and information technology sectors. Its focus areas encompass portfolio management, project management, brand development, and business financing. The firm typically investing €500k - 2m EUR initially and up to 4m in total per company. | Finance |
B.R.A.I.N. Biotechnology Research & Info Network UK Ltd.
B.R.A.I.N. Biotechnology Research & Info Network UK Ltd. BiotechnologyHealth Technology Supplies bio-based products and solutions | Health Technology |
- Stock Market
- Insiders
- Lukas Linnig
















